NanosonicsNNCSF 90 PE Ratio (TTM) is 57.95 as of Jun. 27, 2026, which is 58% below its 10-year median of 138.21. GuruFocus rates NNCSF with a GF Score™ of 90/100 and a GF Value™ of $3.56 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 437 Medical Devices & Instruments companies, Nanosonics ranks worse than 77.8% on this metric.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-06-27), Nanosonics's share price is
$2.55.
Nanosonics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.04. Therefore, Nanosonics's PE Ratio (TTM) for today is 57.95.
Good Sign:
Nanosonics Ltd stock PE Ratio (=48.06) is close to 2-year low of 46.
The historical rank and industry rank for Nanosonics's PE Ratio (TTM) or its related term are showing as below:
NNCSF'
s PE Ratio (TTM) Range Over the Past 10 Years
Min: 26.32 Med: 138.21 Max: 475
Current: 48.79
During the past 13 years, the highest PE Ratio (TTM) of Nanosonics was 475.00. The lowest was 26.32. And the median was 138.21.
NNCSF's PE Ratio (TTM) is ranked worse than 77.8% of 437
companies
in the Medical Devices & Instruments industry
Industry Median: 25.21
vs NNCSF: 48.79
As of today (2026-06-27), Nanosonics's share price is $2.55.
Nanosonics's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was $0.04. Therefore, Nanosonics's PE Ratio without NRI for today is 57.95.
During the past 13 years, Nanosonics's highestPE Ratio without NRI was 475.00. The lowest was 26.32. And the median was 138.21.
Nanosonics's EPS without NRI for the
six
months ended in Dec. 2025 was $0.02.
Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was $0.04.
During the past 12 months, Nanosonics's average EPS without NRIGrowth Rate was 22.20% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 77.40% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 20.20% per year.
During the past 13 years, Nanosonics's highest 3-Year average EPS without NRI Growth Rate was 77.40% per year. The lowest was -35.60% per year. And the median was 14.15% per year.
Nanosonics's EPS (Basic) for the
six
months ended in Dec. 2025 was $0.02.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.04.
Nanosonics (OTCPK:NNCSF) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
Nanosonics PE Ratio (TTM) Related Terms
Nanosonics PE Ratio (TTM) Historical Data
* Premium members only.
The historical data trend for Nanosonics's PE Ratio (TTM) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NNCSF vs ISRG, BDX, MDLN: PE Ratio (TTM) Comparison
For the Medical Instruments & Supplies subindustry, Nanosonics's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nanosonics PE Ratio (TTM) vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nanosonics's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where Nanosonics's PE Ratio (TTM) falls into.
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
Nanosonics's PE Ratio (TTM) for today is calculated as
Nanosonics's Share Price of today is $2.55.
For company reported semi-annually, Nanosonics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.04.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
Nanosonics (NNCSF) has a PE Ratio (TTM) of 57.95 as of Jun. 27, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Nanosonics and its competitors. This is 58% below median its historical median of 138.21. Over the past decade, Nanosonics' PE Ratio (TTM) has ranged from 26.32 to 475.00. According to the industry distribution chart, Nanosonics ranks #340 out of 437 companies in the Medical Devices & Instruments industry, placing it in the top 77.8%.
Is Nanosonics' PE Ratio (TTM) too high?
Nanosonics' current PE Ratio (TTM) of 57.95 is 58% below median its 10-year median of 138.21. Over the past 10 years, this metric has ranged from a low of 26.32 to a high of 475.00. The Medical Devices & Instruments industry median PE Ratio (TTM) is 25.21. Nanosonics' value of 57.95 is 129.9% above this industry median. Based on the distribution chart, Nanosonics ranks #340 out of 437 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Nanosonics has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nanosonics' PE Ratio (TTM) compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Nanosonics ranks #340 out of 437 companies for PE Ratio (TTM). This places Nanosonics in the lower half of its industry. The industry median PE Ratio (TTM) is 25.21. Nanosonics' value of 57.95 is 129.9% above this benchmark. Historically, Nanosonics' own PE Ratio (TTM) has ranged from 26.32 to 475.00 over the past decade. While the company's 10-year median is 138.21 vs. the industry median of 25.21, Nanosonics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Medical Devices & Instruments company?
The median PE Ratio (TTM) among Medical Devices & Instruments companies is 25.21, based on 437 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nanosonics's current PE Ratio (TTM) of 57.95 is 129.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on Nanosonics and its competitors. For the Medical Devices & Instruments industry, the median PE Ratio (TTM) is 25.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nanosonics's current PE Ratio (TTM) is 57.95, which is 58% below median its own 10-year median of 138.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanosonics stock overvalued right now?
Based on GuruFocus' analysis, Nanosonics (NNCSF) is currently considered Modestly Undervalued. The stock's GF Value™ is $3.56, compared to a current price of $2.55 — trading 28.4% below its estimated fair value. The current PE Ratio (TTM) is 57.95, which is 58% below median its 10-year median of 138.21 and 129.9% above the Medical Devices & Instruments industry median of 25.21. Nanosonics' overall GF Score™ is 90/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For Nanosonics (NNCSF), the current PE Ratio (TTM) is 57.95 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nanosonics (NNCSF) Overvalued in 2026?
Based on GuruFocus' analysis, Nanosonics stock appears to be undervalued.
The current stock price of $2.55 is trading 28.4% below its estimated GF Value™ of $3.56.
GuruFocus considers Nanosonics to be Modestly Undervalued.
Key valuation signals for NNCSF:
PE Ratio (TTM): 57.95 (58% below median its 10-year median of 138.21)
GF Value™: $3.56 vs. price of $2.55 (28.4% below fair value)
Industry Position: 129.9% above the Medical Devices & Instruments median (#340 of 437)
No single metric tells the full story. See the NNCSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nanosonics is largely a single-product firm, and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics' revenue consists of capital sales of Trophon units, ongoing consumables sales, and service revenue. By December 2025, there were 38,000 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, over 50% in the US to single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region.
90GF Score
Get the complete analysis for NNCSF
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NNCSF has been successfully added to your 
